Cargando…

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period study

BACKGROUND: Artemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an oral six-dose regimen, given twice daily over three days with one to four tablets (20/120 mg) per dose, depending on patient body weight. In order to reduce the pill burden at each dose and potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lefèvre, Gilbert, Bhad, Prafulla, Jain, Jay Prakash, Kalluri, Sampath, Cheng, Yi, Dave, Hardik, Stein, Daniel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847113/ https://www.ncbi.nlm.nih.gov/pubmed/24010572 http://dx.doi.org/10.1186/1475-2875-12-312

Ejemplares similares

The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
por: Amponsah, Emmanuel Kofi, et al.
Publicado: (2021)

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
por: Tiono, Alfred B, et al.
Publicado: (2015)

Development of a pediatric formulation for treatment of P. falciparum malaria: Coartem(®) (artemether-lumefantrine) Dispersible
por: Bassat, Quique, et al.
Publicado: (2014)

Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia
por: Manyando, Christine, et al.
Publicado: (2015)

Safety and efficacy of lumefantrine-artemether (Coartem(®)) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults
por: Mulenga, Modest, et al.
Publicado: (2006)

Therapeutic efficacy of Artemether/Lumefantrine (Coartem(®)) against Plasmodium falciparum in Kersa, South West Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2010)

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) for the Treatment of Uncomplicated Falciparum Malaria in Africa: A Systematic Review
por: Derbie, Awoke, et al.
Publicado: (2020)

Similar efficacy and safety of artemether-lumefantrine (Coartem(®)) in African infants and children with uncomplicated falciparum malaria across different body weight ranges
por: Bassat, Quique, et al.
Publicado: (2011)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Belew, Sileshi, et al.
Publicado: (2020)

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study
por: Nega, Desalegn, et al.
Publicado: (2016)

Understanding the pharmacokinetics of Coartem(®)
por: Djimdé, Abdoulaye, et al.
Publicado: (2009)

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022)

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects
por: Abdulla, Salim, et al.
Publicado: (2010)

Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product
por: Minzi, Omary MS, et al.
Publicado: (2013)

Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study
por: Ebstie, Yehenew A., et al.
Publicado: (2015)

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
por: Abdulla, Salim, et al.
Publicado: (2009)

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
por: Patel, A., et al.
Publicado: (2012)

Formulation and Bioequivalence of Two Valsartan Tablets After a Single Oral Administration
por: Zaid, Abdel Naser, et al.
Publicado: (2011)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
por: Juma, Elizabeth A, et al.
Publicado: (2008)

Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects
por: Tjandrawinata, Raymond R, et al.
Publicado: (2012)

Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers
por: Jain, Jay Prakash, et al.
Publicado: (2017)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions
por: Tjandrawinata, Raymond R, et al.
Publicado: (2013)

Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
por: Meulman, Jessica, et al.
Publicado: (2023)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Ali, Shabana, et al.
Publicado: (2010)

Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations
por: Rasmussen, Scott C., et al.
Publicado: (2017)

Coartem(®): the journey to the clinic
por: Premji, Zulfiqarali G
Publicado: (2009)

Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions
por: Li, Qiuying, et al.
Publicado: (2021)

Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
por: Singhal, R., et al.
Publicado: (2011)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
por: Prah, James, et al.
Publicado: (2016)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
por: Ghimire, Prakash, et al.
Publicado: (2018)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019
por: Dimbu, Pedro Rafael, et al.
Publicado: (2021)

Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions
por: Davanço, Marcelo Gomes, et al.
Publicado: (2023)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
por: Tchaparian, Eskouhie, et al.
Publicado: (2016)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010)

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
por: Chen, Yu-Luan, et al.
Publicado: (2023)

Bioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg)Tablets in Healthy Volunteers
por: Jung, Sang-hoon, et al.
Publicado: (2014)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b1vkt5lr5tjmg0sjru0r8it1ok